Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
Clinical trial NCT02895906 · COMPLETED
Trial details
- NCT number
- NCT02895906
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2017-04-13
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.